Adverse effects of the treatment for hyperlipidemia.
A variety of treatments to lower elevated plasma lipid levels in patients with hyperlipidemia are available. Adverse side effects ranging from mere annoyances to uncommon serious consequences may be associated with dietary modification, recreational physical exercise, and drug intervention. As in other clinical circumstances, risk-to-benefit ratios must be taken into consideration in the management of hyperlipidemia.
D000837:Anion Exchange Resins / Q000009:adverse effects; D000924:Anticholesteremic Agents / Q000009:adverse effects; D001634:Bibliographies as Topic; D002994:Clofibrate / Q000009:adverse effects; D004032:Diet / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000009:adverse effects; D015248:Gemfibrozil; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects; D008297:Male; D009355:Neomycin / Q000009:adverse effects; D009525:Niacin / Q000009:adverse effects; D010421:Pentanoic Acids / Q000009:adverse effects; D005082:Physical Exertion; D011341:Probucol / Q000009:adverse effects; D012306:Risk
D000837:Anion Exchange Resins; D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D009525:Niacin; D002994:Clofibrate; D009355:Neomycin; D011341:Probucol; D015248:Gemfibrozil